Literature DB >> 15056125

Smoking cessation and glycaemic control in type 2 diabetic patients.

K Iino1, M Iwase, N Tsutsu, M Iida.   

Abstract

AIM: To elucidate the relationship between glycaemic control, blood pressure and body-weight change after smoking cessation in type 2 diabetic patients.
METHODS: We examined HbA(1c), blood pressure and body weight in 15 type 2 diabetic patients before, 6 and 12 months after quitting smoking. Sixteen type 2 diabetic patients who did not quit smoking served as control.
RESULTS: Body weight slightly increased after quitting smoking. Although HbA(1c) levels showed no change in the control group, those in patients who quit smoking significantly increased (6.8 +/- 0.3% before quitting smoking; 7.4 +/- 0.3% 6 months after quitting smoking, p < 0.05; 7.8 +/- 0.4% 12 months after quitting smoking, p < 0.001). Fasting blood glucose also increased in patients who quit smoking. The increase in body weight after quitting smoking did not correlate with the deterioration of glycaemic control. Diastolic blood pressure showed no change in control, whereas that in patients who quit smoking increased at month 12 (69 +/- 3 vs. 76 +/- 3 mmHg, p < 0.01). The increase in HbA(1c) at month 12 after quitting smoking correlated with body mass index before quitting smoking (r = 0.72, p < 0.005) and serum triglyceride before quitting smoking (r = 0.68, p < 0.01).
CONCLUSIONS: Glycaemic control and diastolic blood pressure deteriorated in type 2 diabetic patients after quitting smoking. Type 2 diabetic patients who want to stop smoking need a caution to prevent deterioration of glycaemic control and blood pressure after quitting smoking.

Entities:  

Mesh:

Substances:

Year:  2004        PMID: 15056125     DOI: 10.1111/j.1462-8902.2004.00329.x

Source DB:  PubMed          Journal:  Diabetes Obes Metab        ISSN: 1462-8902            Impact factor:   6.577


  9 in total

Review 1.  Smoking cessation in adults with diabetes: a systematic review and meta-analysis of data from randomised controlled trials.

Authors:  Alexander Nagrebetsky; Rachel Brettell; Nia Roberts; Andrew Farmer
Journal:  BMJ Open       Date:  2014-03-06       Impact factor: 2.692

2.  The effect of quitting smoking on HDL-cholesterol - a review based on within-subject changes.

Authors:  Barbara A Forey; John S Fry; Peter N Lee; Alison J Thornton; Katharine J Coombs
Journal:  Biomark Res       Date:  2013-09-13

Review 3.  Relationship of cardiometabolic parameters in non-smokers, current smokers, and quitters in diabetes: a systematic review and meta-analysis.

Authors:  Debasish Kar; Clare Gillies; Francesco Zaccardi; David Webb; Samuel Seidu; Solomon Tesfaye; Melanie Davies; Kamlesh Khunti
Journal:  Cardiovasc Diabetol       Date:  2016-11-24       Impact factor: 9.951

4.  Smoking in men and women with type 2 diabetes: A qualitative gender-sensitive exploration of barriers to smoking cessation among people with type 2 diabetes.

Authors:  Aurélien Georges; Laura Galbiati; Carole Clair
Journal:  PLoS One       Date:  2019-08-28       Impact factor: 3.240

Review 5.  Cardiometabolic Morbidity and Mortality with Smoking Cessation, Review of Recommendations for People with Diabetes and Obesity.

Authors:  Katarina Kos
Journal:  Curr Diab Rep       Date:  2020-12-08       Impact factor: 4.810

6.  Improvement in Cardiometabolic Risk Factors During Smoking Cessation Treatment in Patients with Type 2 Diabetes: A Retrospective Cohort Study.

Authors:  Hsin-Ju Chen; Wei-Hsin Huang; Hsin-Lung Chan; Lee-Ching Hwang
Journal:  Diabetes Metab Syndr Obes       Date:  2021-04-16       Impact factor: 3.168

7.  Antipsychotic-induced metabolic and cardiovascular side effects in schizophrenia: a novel mechanistic hypothesis.

Authors:  Giulio Scigliano; Gabriele Ronchetti
Journal:  CNS Drugs       Date:  2013-04       Impact factor: 5.749

8.  Contingency management for smoking cessation among individuals with type 2 diabetes: protocol for a multi-center randomized controlled feasibility trial.

Authors:  Sydney A Martinez; Samantha L Quaife; Afsheen Hasan; Kathryn A McMillan; Laura A Beebe; Fiona Muirhead
Journal:  Pilot Feasibility Stud       Date:  2020-06-11

Review 9.  Smoking and diabetes: dangerous liaisons and confusing relationships.

Authors:  D Campagna; A Alamo; A Di Pino; C Russo; A E Calogero; F Purrello; R Polosa
Journal:  Diabetol Metab Syndr       Date:  2019-10-24       Impact factor: 3.320

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.